|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
2
Can Predictive Modelling Fix Fragmented Pharma Development Data?
3
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
4
Pharma's Next AI Problem Is Authority
5
